Showing 2 posts of 2 posts found.


Allergan’s depression drug rapastinel fails to outperform placebo at Phase 3

March 7, 2019
Research and Development Allergan, FDA, depression, major depressive disorder, pharma, rapastinel

As Janssen celebrated the FDA approval of the first novel therapy for depression in three decades with Spravato, Allergan released …


Allergan’s depression drug awarded FDA Breakthrough Therapy status

January 29, 2016
Research and Development, Sales and Marketing Allergan, depression, rapastinel

While still adjusting to life as part of Pfizer, Allergan has received some good news in the form of the …

Latest content